Global Pen Needles (Insulin, Glucagon-like peptide, Growth Hormones) Market - Analysis & Forecast to 2019

News provided by

Nov 13, 2014, 05:59 ET

DUBLIN, November 13, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/gln9j8/pen_needles) has announced the addition of the "Pen Needles Market by Type, Needle Length, Therapy - Analysis & Global Forecast to 2019" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The pen needles market is highly competitive with a large number of players, including both big and small players, operating in this market. Needles are used by patients to deliver insulin daily to their body. Rise in the global diabetic population and the increasing need for safety injections have resulted in technological advancements in this field.

The global pen needles market is segmented on the basis of type, needle length, therapy, and region. By type, the pen needles market is categorized into standard and safety needles. The standard pen needles segment is expected to account for the largest share of the market, by type. However, the safety needles segment is expected to grow at the fastest rate in the market, by type.

On the basis of needle length, the market is divided into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. Pen needles with 6mm length is expected to account for the largest share of the market, by needle length. However, the needles with 4mm length are expected to grow at the fastest rate in the market, by needle length.

The pen needles market, by therapy is segmented into insulin, Glucagon-like peptide (GLP), and growth hormones. Insulin therapy is the largest (2014) and fastest (2014-2019) growing market of the market, by therapy.

The key factors that are expected to spur the growth of this market are the rising global diabetic population, favorable reimbursement scenario in North America and Europe, technological advancements, and awareness campaigns and conferences to improve diabetes care and adoption market. However, poor reimbursement structure in developing countries, rising incidents of needlestick injuries (NSIs), and threats involved in reuse of pen needles are hindering the market growth.

On the basis of region, this market is classified into North America, Europe, Asia, and Rest of the World (RoW).

The global pen needles market is expected to reach $2,105 million in 2019 from $1,283 million in 2014, growing at a CAGR of 10.4%. The market is dominated by Europe, followed by North America, Asia, and Rest of the World (RoW). Asia is expected to reach leadership position in terms of the value by 2019.

Some of the major players in the global market include Becton, Dickinson and Company (U.S.), Novo Nordisk (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-Strefa S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd (U.K.), Allison Medical, Inc. (U.S.), and Ultimed, Inc. (U.S.).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Pen Needles Market, By Type

8 Pen Needles Market, By Length

9 Pen Needles Market, By Therapy

10 Pen Needles Market, By Geography

11 Competitive Landscape

12 Company Profiles

13 Appendix